RECK Antikörper (AA 23-212) (FITC)

Produktnummer ABIN7167893

Produktdetails anti-RECK Antikörper (FITC)

Target: RECK (Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK))

Bindungsspezifität: AA 23-212

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RECK Antikörper ist konjugiert mit FITC

Applikation: Bitte anfragen

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Reversion-inducing cysteine-rich protein with Kazal motifs protein (23-212AA)

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu RECK

Target: RECK (Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK))

Andere Bezeichnung: RECK (RECK Produkte)

Hintergrund:

Background: Negatively regulates matrix metalloproteinase-9 (MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.

Aliases: hRECK antibody, Membrane anchored glycoprotein (metastasis and invasion) antibody, RECK antibody, RECK protein antibody, RECK_HUMAN antibody, Reversion inducing cysteine rich protein with Kazal motifs antibody, Reversion-inducing cysteine-rich protein with Kazal motifs antibody, ST15 antibody, Suppression of tumorigenicity 15 (reversion inducing cysteine rich protein with kazal motifs) antibody, Suppressor of tumorigenicity 15 antibody, Suppressor of tumorigenicity 15 protein antibody

UniProt: O95980